ConductScience.org, home

Gene · 8506

CNTNAP1: contactin associated protein 1

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. CNTNAP1: contactin associated protein 1. Genes, record 8506. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8506

On this page

Gene

Symbol
CNTNAP1
HGNC
Name
contactin associated protein 1
HGNC
NCBI Gene ID
8506
NCBI Gene
HGNC ID
HGNC:8011
HGNC
Ensembl
ENSG00000108797
NCBI Gene
Aliases
CASPR, CHN3, CNTNAP, Caspr, NRXN4, P190, p190
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P78357Contactin-associated protein 11,3840Ensembl, GeneID, HGNC

Source UniProt

Patents29

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-192374P78357Espacenet
EP 4640849 A22025-10-29281P78357Espacenet
EP 4641201 A22025-10-291947P78357Espacenet
EP 4641202 A22025-10-29118P78357Espacenet
EP 4641203 A22025-10-2977P78357Espacenet
JP 2025529142 A2025-09-041069P78357Espacenet
US 12371689 B22025-07-291069P78357Espacenet
JP 2025519096 A2025-06-24281P78357Espacenet
JP 2025517967 A2025-06-1277P78357Espacenet
JP 2025517969 A2025-06-121947P78357Espacenet

1 to 10 of 29

See all 29 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,045

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCNTNAP1 papersNewest fiscal year
P30CA016672Cancer Center Support Grant232025
P30CA008748Cancer Center Support Grant102025
P01CA018029Adult Leukemia Research Center62025
P30CA062203Cancer Center Support Grant42025
T32CA009054A Training Program for Interdisciplinary Cancer Research42025
P30CA016058Cancer Center Support Grant32025
P30DK034854Integrated Epithelial and Muscosal Biology32025
T32CA009109Cancer Research Training Program: From Molecular Mechanisms to Therapeutic Strategies32025
P30CA021765Cancer Center Support Grant (CCSG)22025
P30CA033572Cancer Center Support Grant22025

1 to 10 of 1,045Source NIH's project files

See all 1,045 nih grants

Papers1,771

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Dual-Driver Myeloproliferative Neoplasm: Concurrent p190 BCR::ABL1 CML and JAK2 V617F Mutation: A Case Report and Literature Review.Case Rep Hematol202642781115PubTator, text miningPubMed
Pathophysiology and Emerging Therapies in Chronic Inflammation Demyelinating Polyneuropathy.Intern Med202642749655PubTator, text miningPubMed
Successful induction of remission with azacitidine, venetoclax, and dasatinib followed by allogeneic hematopoietic stem cell transplantation in a patient with Philadelphia chromosome-positive mixed phenotype acute leukemia (B/myeloid): a case report.
Front Med (Lausanne)202642746482PubTator, text miningPubMed
Revisiting Asciminib Resistance: From Binding Affinity to Allosteric Disruption in BCR::ABL1 Leukemias.Turk J Haematol202642706725PubTator, text miningPubMed
BCR::ABL1 e1a2 (p190)-Positive Myeloid Blast Neoplasm: Diagnostic Challenges in Distinguishing De Novo Acute Myeloid Leukemia From Previously Unrecognized Chronic Myeloid Leukemia in the Blast Phase.Cureus202642667018PubTator, text miningPubMed
Clonal and genomic determinants of e1a2 BCR::ABL1 chronic myeloid leukemia: A Fi-LMC study.Hemasphere202642549430PubTator, text miningPubMed
Neuro-renal syndrome (NRS) in autoimmune nodopathies and paranodopathies: A warning to consider the diagnosis when anti-node and paranode antibody tests are difficult to perform.J Neurol Sci202642497634PubTator, text miningPubMed
Autoimmune nodopathies: a clinical review.Clin Neurophysiol202642492459PubTator, text miningPubMed
An Unusual Presentation of Philadelphia Chromosome Positive B-Cell Acute Lymphoblastic Leukemia With Isolated Osteolytic Lesions at Diagnosis: A Case Report.Case Rep Hematol202642472062PubTator, text miningPubMed
Development and validation of an in-house one-step RT-qPCR method for the quantification of the BCR::ABL1 p210 transcripts.Sci Rep202642457813PubTator, text miningPubMed

1 to 10 of 1,771

See all 1,771 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/8506

GET https://conductscience.org/api/genes/v1/8506/patents?page=2